 The purpose of this study is to monitor the performance of artificial hip joints implanted with two different bone cements, SmartSet HV and SmartSet GHV, in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to SmartSet HV or SmartSet GHV and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments 